The firm is hoping that the CRISPR/Cas9-edited TILs will have anti-tumor activity with long-term persistence against various solid tumors.

Alpenglow hosts AACR 2025 Dinner Lecture on endometrial cancer with Dr. Sammy Ferri-Borgogno, showcasing 3D spatial biology ...